We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Bifunctional Fc-Based Fusion Protein Therapies: From Concept to the Clinic - Session 1

Bifunctional Fc-Based Fusion Protein Therapies: From Concept to the Clinic - Session 1 content piece image

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics. At Shattuck Labs, we have pioneered the development of bifunctional Fc-based fusion protein technologies that are designed to have potential therapeutic applications in oncology and autoimmunity. In this webinar, our expert speaker will describe the concept behind the fusion protein technology and how ThermoFisher Scientific’s GeneArt protein production service has been integrated into the preclinical workflow during the startup stage and evolution of Shattuck Labs’ R&D function.   


Attend this webinar to learn:

  • The principles of bi-functional fusion protein design
  • The value of incorporating transient protein production for candidate screening and lead selection
  • How to generate a preclinical data package to support an investigational new drug filing
Speaker
Dr. Suresh de Silva
Dr. Suresh de Silva
Chief Scientific Officer, GALDEN Platform at Shattuck Labs